After an academic career in microbiology, Chloé completed a PhD at the Pasteur Institute on the production and entry of botulinum toxins in the intestine, and a post doctoral degree at IBENS on the transcriptomic modification of intestinal cells during an infection with L. monocytogenes.
Subsequently, Chloé wanted to work in scientific innovation, and after a short experience as a consultant in innovation financing, she worked at Axelys Santé, a CRO specialized in medical and pharmaceutical affairs, as a development and innovation manager.
Chloé joins MetaGenoPolis in July 2020 as Project Manager Officer and will be in charge of monitoring the unit’s projects.